Results 171 to 180 of about 4,726 (262)

Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy. [PDF]

Theranostics
Yin JY, Liu HM, Li SL, Ji XQ, Wang JJ, Fu MJ, Liu CJ, Wang N, Lu GL, Li Y, Liu HM, Zheng YC, Dai XJ, Liu Y.   +13 more
europepmc   +1 more source

Unlocking the mystery of the PD-1/PD-L1 axis: beyond the checkpoint hype. [PDF]

Front Immunol
Desimpel PH, Petit PF, J Van den Eynde B, Zhu J.   +3 more
europepmc   +1 more source

Emergence, function, and therapeutic strategies to target the PD-1/PD-L1 immune checkpoint during pathogenic fungal infections. [PDF]

Virulence
Zheng X, He X, Song Z, Chen W, Liu F.
europepmc   +1 more source

Beyond monoclonal antibodies: constraints and the case for alternative PD-1/PD-L1-targeting formats. [PDF]

Front Immunol
Porozova NO, Petukhova NV, Gureev MA, Moiseev IS, Eliseev IE, Fedorova LV, Porozov YB.   +6 more
europepmc   +1 more source

SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy. [PDF]

Mol Cancer
Li J, Fan T, Wang D, Xiao C, Deng Z, Cai W, Ji Y, Li C, He J.   +8 more
europepmc   +1 more source

Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics. [PDF]

Molecules
Gao Y, Xing S, Hu L.
europepmc   +1 more source

The Search for Predictive Biomarkers in Response to Immune Checkpoint Inhibitors and Associated Adverse Events. [PDF]

J Pers Med
Agostini M, Traldi P, Hamdan M.
europepmc   +1 more source

Nanomedicine targeting the PD-1/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance. [PDF]

J Nanobiotechnology
Xiang G, Cui Y, Wang P, Feng Y, Zhang C, Lou J, Zhou X.   +6 more
europepmc   +1 more source

Investigating the effect of ceramic fiber on the mechanical properties of glassphalt. [PDF]

Sci Rep
Dehnad MH, Yazdi A, Hamedi GH.
europepmc   +1 more source

The Role of PD-L1 in Lung Cancer: From Biology to Clinical Application. [PDF]

Immunotargets Ther
Lamghari H, Karkouri M.
europepmc   +1 more source